Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Scott

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
Journal of the Royal Society of Medicine|January 1, 1983
Ultrastructure of the synovial membrane in seronegative inflammatory arthropathiesC J Morris, M Farr, C A Hollywell, et al.
Clinical Rheumatology|November 1, 1996
Standardising joint assessment in rheumatoid arthritisD L Scott, E H Choy, A Greeves, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology ResearchD L Scott, G S Panayi, P L van Riel, et al.
Analytical Chemistry|December 24, 1997
Detecting biomolecules in picoliter vials using aequorin bioluminescenceC L Crofcheck, A L Grosvenor, K W Anderson, et al.
The Journal of Rheumatology|July 1, 1982
The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other diseasesD L Scott, T J Almond, S N Naqvi, et al.
Annals of the Rheumatic Diseases|June 1, 1989
What proteins are present in polyethylene glycol precipitates from rheumatic sera?M W Robinson, D G Scott, P A Bacon, et al.
British Journal of Experimental Pathology|April 1, 1982
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulinD J Unsworth, D L Scott, T J Almond, et al.
Clinical and Experimental Rheumatology|June 29, 2013
Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteriaHelen Linklater, Nicolò Pipitone, Michael R Rose, et al.
Science (New York, N.Y.)|November 15, 1991
Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudateD L Scott, S P White, J L Browning, et al.
Annals of the Rheumatic Diseases|November 1, 1986
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapyP T Dawes, P D Fowler, R Jackson, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Journal of the Royal Society of Medicine|January 1, 1983
Ultrastructure of the synovial membrane in seronegative inflammatory arthropathiesC J Morris, M Farr, C A Hollywell, et al.
Clinical Rheumatology|November 1, 1996
Standardising joint assessment in rheumatoid arthritisD L Scott, E H Choy, A Greeves, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology ResearchD L Scott, G S Panayi, P L van Riel, et al.
Analytical Chemistry|December 24, 1997
Detecting biomolecules in picoliter vials using aequorin bioluminescenceC L Crofcheck, A L Grosvenor, K W Anderson, et al.
The Journal of Rheumatology|July 1, 1982
The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other diseasesD L Scott, T J Almond, S N Naqvi, et al.
Annals of the Rheumatic Diseases|June 1, 1989
What proteins are present in polyethylene glycol precipitates from rheumatic sera?M W Robinson, D G Scott, P A Bacon, et al.
British Journal of Experimental Pathology|April 1, 1982
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulinD J Unsworth, D L Scott, T J Almond, et al.
Clinical and Experimental Rheumatology|June 29, 2013
Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteriaHelen Linklater, Nicolò Pipitone, Michael R Rose, et al.
Science (New York, N.Y.)|November 15, 1991
Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudateD L Scott, S P White, J L Browning, et al.
Annals of the Rheumatic Diseases|November 1, 1986
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapyP T Dawes, P D Fowler, R Jackson, et al.
Pageof 32